<DOC>
	<DOCNO>NCT00912353</DOCNO>
	<brief_summary>This Phase I , single center , randomize , double-blind , placebo-controlled single ascend oral dose study assess safety , tolerability pharmacokinetics AZD7268 healthy Japanese subject .</brief_summary>
	<brief_title>AZD7268 Single Ascending Dose Study Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese male female ( nonchild bear potential ) subject 20 45 year age , inclusive Body weight 50 90 kg , inclusive , Body Mass Index ( BMI ) 18 â‰¤ 27 kg/m2 Clinically relevant disease disorder ( past present ) , opinion investigator , may either put subject risk participation study influence result subject 's ability participate study Any clinically significant abnormality physical examination , vital sign , clinical chemistry , hematology urinalysis result judge investigator and/or sponsor Smoking excess 5 cigarette per day equivalent within 30 day Day 1</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japanese healthy volunteer</keyword>
	<keyword>AZD7268</keyword>
</DOC>